Specifically, IDH1 (Isocitrate Dehydrogenase 1), TP53 (Tumor Protein P53), and ATRX (ATRX Chromatin Remodeler) were the most frequently mutated genes among the glioma samples. This evidence concerns the gene ATRX and central nervous system cancer.